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Abstract.  The coding region of the hamster desmin 
gene was fused to the 5' flanking sequences of the 
hamster vimentin gene and introduced into the germ 
line of mice. The expression of this intermediate fila- 
ment gene construct (pVDes) was analyzed at the 
RNA and protein level in transgenic mice as well as in 
fibroblast cell lines and primary hepatocyte cultures 
derived from these mice. In all transgenic mice, the 
pVDes-encoded protein was coexpressed with mouse 
vimentin in a tissue-specific fashion and was indistin- 
guishable from normal hamster desmin.  Culturing  of 
transgenic hepatocytes induced desmin expression indi- 
cating that 3.2 kbp of the vimentin gene 5' region 
regulates both tissue-specific and tissue culture-in- 
duced intermediate filament protein expression.  Im- 
munohistochemical  staining and double-label immuno- 
electron microscopy of cultured transgenic  fibroblasts 
showed that the pVDes protein assembled into inter- 
mediate filaments which colocalized with the mouse 
vimentin filaments.  Endogenous vimentin RNA levels 
were not influenced by high-level pVDes expression. 
The coexpression of desmin and vimentin in nonmus- 
cle cells did not result in detectable developmental, 
morphological,  or physiological abnormalities. 
I 
NTERMEDIATE filaments (IFs) ~  represent a unique group 
of cytoskeletal structures  that occur in the cytoplasm of 
virtually all  mammalian  cells.  The expression  of the 
different  classes  of IF  subunits  is  regulated  in  a  tissue- 
specific and developmentally  regulated  fashion.  Generally, 
cytokeratins are expressed in cells of epithelial  origin while 
neurofilaments  are expressed in neuronal  cells,  glial fibril- 
lary acidic protein in astrocytes,  desmin almost exclusively 
in  striated  and  most  smooth muscle cells,  and  vimentin 
mainly in cells of mesenchymal  origin (58, 59, 64). The ex- 
pression of the nuclear lamins, which are part of the IF mul- 
tigene family, is also cell type specific and developmentally 
regulated (12, 29, 61). The highly conserved specificity of IF 
subunit  expression during  development suggests that  each 
type of subunit plays an important  role in cellular differenti- 
ation. 
On the basis of gene structure and sequence data,  the IF 
subunits have been divided into four subfamilies.  Vimentin 
(47),  desmin (48),  glial  fibrillary  acidic protein (40),  and 
possibly a recently described neurofilament protein (39) dis- 
play a high degree of homology and constitute one subfamily 
of proteins  (type III subunits).  Like the other IF proteins, 
1. Abbreviation used in this paper:  IF,  intermediate filament. 
they have  a  conserved central  a-helical  domain of ~,310 
amino acid residues,  flanked by nonhelical  amino-terminal 
and  carboxy-terminal  domains  of variable length  and  se- 
quence (12, 22, 58, 59, 64). In view of the highly  specific 
expression pattern of each IF subunit, it may be assumed that 
their variable terminal  regions at least partly determine the 
specific properties that are needed in different cell types dur- 
ing various  stages of development  (23, 38, 58). 
The  vimentin  expression  pattern  is relatively  complex. 
During embryogenesis,  vimentin is the first of the nonepithe- 
lial subunits to be expressed (18, 30). The appearance of the 
cell type-specific IF subunits is often preceded by vimentin 
expression,  and in certain cases coexpression with the other 
types of IF is observed (9, 19, 37, 56, 57, 64, 65). When non- 
mesenchymal  cells are dissociated from tissues and brought 
into culture, induction of vimentin synthesis often occurs (15, 
64). This is mostly accompanied by the continued coexpres- 
sion of the tissue-specific  IF protein,  but in some cases only 
vimentin  expression  remains (6, 17). The level of vimentin 
expression  is growth  regulated  and  can be stimulated  by 
some growth  factors  (11, 54).  This complex expression  is 
mediated by multiple  regulatory elements  in the 5' flanking 
sequence of the vimentin  gene (46, 54). 
In cultured cells, the study of cell type-specific regulation 
and function  of IF expression is  necessarily limited.  The 
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The Journal of Cell Biology, Volume 108, March 1989  1009-1024  1009 Figure 1.  (A) Schematic representation of the IF gene construct pVDes (not drawn to scale). The line on the left represents the vimentin 
gene 5' flanking region (from -3,100 to +101  relative to vimentin cap site). Bar represents the desmin gene with black regions indicating 
the desmin 5'- and 3' untranslated  sequences, hatched regions indicating exons, and open regions indicating the introns.  Positions of the 
vimentin-specific (E49) and desmin-specific (X54) probes are indicated. E, Eco RI restriction site; B, Bam HI restriction site. (B) Southern 
blot analysis of tail DNA from mice transgenic for pVDes.  +10 #g of DNA was digested with Eco RI. Hybridization was performed with 
the vimentin probe E49.  Asterisk indicates position of the 8.5-kbp Eco RI fragment from the single copy mouse vimentin gene. Arrow 
indicates position of the 5.15 -kbp EcoRI fragment from pVDes. (Lane 1 ) DNA from offspring of founder 430; (lane 2) DNA'  from founder 
430;  (lanes 3  and  7) DNA from control mice; (lanes 4  and 5) DNA from offspring of founder 426;  (lane 6) DNA from founder 426; 
(lanes 8  and 9) DNA from offspring of founder 429;  and (lane 10) DNA from founder 429. 
phenomenon of tissue culture-induced vimentin expression 
is not understood. The observations, that some cell lines do 
not express IFs (27, 41, 64) and that disruption of IFs does 
not affect growth or morphology of cultured cells (21, 34, 
42), indicate that IFs-at least in vitro-do not fulfill an es- 
sential cellular function (13). 
Transgenic mice, which have proven to be useful in the 
study of tissue-specific gene expression (for review,  see ref- 
erence 44), provide a better system to study IF gene regula- 
tion and function. Our approach was to change the normal 
IF expression pattern by introducing an IF gene construct 
into the germ line of mice composed of the 5' flanking region 
of the vimentin gene and the complete coding region of the 
desmin gene. Transgenic mice, primary cell cultures, and 
cell lines derived from these mice were analyzed for the pat- 
tern and levels of desmin and vimentin expression. 
Materials and Methods 
Plasmid Construction 
For construction of the pVDes gene, the 0.7-kpb Hpa II-Bam HI fragment 
from the hamster desmin gene (from  +25 bp to +700 bp relative to the cap 
site; reference 48) was subcloned into an Acc I-Bam HI-digested pUC19 
plasmid. The 3.2-kbp Barn HI-Eco RI (from +700 to +3,900) and the 3.4- 
kbp Eco RI-Stu I (from  +3,900 to +7,300) desmin fragments were ligated 
immediately 3' to this fragment, thereby generating a complete desmin gene 
(pDes) without 5' sequences upstream of the Hpa II site at +25. In this con- 
struct, 60 bp of 5'- and 775 bp of 3' untranslated sequences (including the 
"poly A" signal) are present. The 3.2-kbp vimentin promoter region (ranging 
from  -3,100 to  +101 relative to the vimentin cap site) was isolated as a 
Hind III fragment by ligating the 3.45-khp Bam HI-F.co RI fragment from 
p3.1VimCAT (46) into an Eco RI-Bam HI-digested pUC19 plasmid,  and 
subsequent partial Hind III digestion of this clone. This vimentin 5' region 
was ligated into the Hind III site of the pUC19 polylinker of pDes in the 
5'-3' orientation. The resulting construct (pVDes) contains some additional 
base pairs from the pUCI9 polylinker between the Hind HI and the Acc I 
site. To facilitate removal of plasmid sequences before mieroinjection,  the 
Barn HI site in the first intron of  desmin was removed by filling in and subse- 
quent blunt end iigation after partial  Bam HI digestion. 
Generation and Identification of Transgenic Mice 
Transgenic mice were generated by pronuclear microinjection as described 
previously (36). Plasmid sequences were removed by Barn HI (5' complete) 
and Eco RI (Y, partial) digestion,  leaving a 10.5-kbp IF hybrid gene. This 
was isolated and purified by preparative gel electrophoresis and electroelu- 
tion, dissolved in ultrapure water, and dialyzed against  10 mM Tris-HCl, 
0.1 M EDTA (pH 7.4). The DNA concentration  was adjusted to 4 #g/ml, 
and +200 pVDes copies were injected. Several weeks after birth of animals 
that had developed from microinjected eggs, tail DNA was isolated and ana- 
lyzed by Southern blotting. Briefly, equal amounts (10 #g) of total genomic 
DNA of each mouse was digested with the appropriate restriction enzyme(s), 
run on a 0.6% agarose gel, and transferred to nitrocellulose.  The filter was 
hybridized to 32p-labeled probes (see below) and washed as described (5). 
The number of integrated pVDes copies was determined by Southern blot 
analysis of serial dilutions of tail DNA, using the vimentin-specific probe 
E49, and subsequent densitometric scanning of the autoradiographs, pVDes 
hybridization  signals were  compared  to those  of the single copy mouse 
vimentin gene and of serial dilutions of the pVDes plasmid. 
Northern Blot Analysis and Hybridization Probes 
Total cellular RNA was isolaaxt from tissues and cultured cells by the LiCI- 
urea method of Auffray and Rougeon (1). Primer extension analysis on total 
cellular RNA from ear fibroblast cell lines was performed as described (24, 
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CA~GCCC-3';  from +25 to +46 relative to the transcription initiation 
site). For Northern blotting, 10-, 15-, or 20-/tg RNA samples were giyox- 
ylated, fractionatedOn a 1.2% agarose gel, and transferred to Highbond-N 
(Amersham International, Amersham, UK). Hybridization was performed 
as described by Church and Gilbert (5). A 350-bp hamster desmin Sau3A 
fragment in M13 (X54), covering a region from 25 bp of exon 8 to 120 bp 
into the 3' untranslated region, was used as a desmin probe (46, 48). A 
520-bp hamster vimentin Sau3A fragn~nt in MI3, ranging from -150 to 
+370 bp relative to the cap site, was nsed ns a vimentin probe (46, 47). As 
an actin probe, we used a 1.25-kbp Pstl hamster nctin cDNA fragment (8), 
which hybridizes to a-,/$-, and T-nctin.  Densitometric scanning was per- 
formed on autoradiographs exposed for different  times. 
Cell Culture 
Ear fibroblast cell lines were established and cultured as described (3). 
Mouse hepatocytes  were isolated and cultured using the hepatic portal 
perfusion method as described by Klaunig et al. (32, 33), with the following 
modifications.  Instead of Hanks' solution, Williams E medium (Flow Lab- 
oratories, Inc., McLean, VA) supplemented with 2.5 mM EGTA was used. 
Hepatocytes were cultured in Williams E medium supplemented with 10% 
FCS, 2 mM L-glutamine, 20 mU/ml bovine insulin, 1 ttM dexamethasone, 
and antibiotics (25 ttg/rnl fungizone;  100 gg/ml vancomycin; 50/~g/ml gen- 
tamycin). 
Gel Electrophoresis and Immunoblotting 
Cytoskeletal preparations of eye lens and cultured cells were obtained as de- 
scribed (35). One- and two-dimensional  SDS gel electrophoresis and immu- 
noblotting procedures have also been described previously  (4). 
lmmunohistochemical Analysis 
Single-  and double-label indirect immunofluorescence  analyses of frozen 
tissue sections and cultured cells were performed as described previously 
(36).  In the underlying study, however, muscle tissue sections were pre- 
treated with 0.5% Triton X-100 in PBS before incubation with the first anti- 
bodies. The following polyclonal and monoclonal antibodies were used: (a) 
an affinity-purilied  polyclonal  rabbit antibody (poly-ker) raised against hu- 
man skin keratins, which reacts with virtually all epithelial tissues (51); (b) 
an afffinity-purified polyclonal  rabbit antibody (poly-vim) to vimentin (51); 
(c) a polyclonal rabbit antibody (poly-des) to desmin (52); (d) the monoclo- 
hal antibody RV202 to vimentin (4); (e) the monoclonal antibody RD301 
to desmin (4); and Or) the monoclonal antibody RCK 102 to human cytoker- 
atins 5 and 8 (53). 
lmmunoelectron Microscopy 
Transformed fibroblnsts  from control and transgenic mice were grown on 
Thermanox coverslips (Lux, Lab-Tek Div., Miles Laboratories Inc., Naper- 
ville, IL), coated with fibrouectin  by a 30-min incubation with a crude prep- 
aration from human serum. Cells at ,075%  confluency were washed with 
double Hanks' buffer and converted to cymskeletons  by extraction for 2.5 
min at room tunperam~, with a buffer (pH 7.2)  containing 0.5% Triton 
X-100 as described by T611e  et al. (63), and fixed in buffered 0.5% parafor- 
maldehyde  containing 0.3%  Triton X-100 (pH'Z2). The cells were pro- 
cessed for immtlnogold labeling and electron microscopy essentially as de- 
scribed by De Mey (7) and as in AmoPmbe EM product information 
(Janssen Phannnceutica, Beesse, Belgium). 'lb reduce background staining 
the coverslips  we~ preincuba__ted  for 20 rain with a TBS solution (pH 8.2) 
containing 10% normal goat serum and 0.1% lISA. The monoclonal and 
polyclonal  antibodies were diluted in a similar buffer containing 1% nor- 
mal goat serum and 0.1% Tween-20. Washing buffers also contained 0.1% 
Tween-20.  Furthermore, the 5-nm and 10-rim antibody-coated colloidal 
gold preparations (Janssen Phammceuticu) were preabsorbed extensively 
on flbroblast  cytoskeleCms and diluted in Tris buffer, pH 8.2, containing 1% 
BSA. 
Results 
Generation of Transgenic Mice 
We have demonstrated previously that the structural gene for 
hamster desmin and modifications  thereof can be expressed 
after gene transfer into different types of cultured nonmuscle 
cells resulting  in assembly of the newly synthesized protein 
into intermediate  filaments  (28, 48). Regulatory sequences 
which control desmin expression are located in a region be- 
tween  -89 and  +25 relative  to the transcription  initiation 
site (46). We removed these regulatory elements by deleting 
the complete 5' flanking region of the desmin gene up to the 
HpaII site at position +25, and replaced it by 3.2 kbp of 5' 
flanking sequences (-3,100-+101) from the hamster vimen- 
tin gene (Fig. 1 A). This upstream region contains regulatory 
elements  that  confer high levels of vimentin  expression in 
cultured cells and are instrumental  in the down-regulation  of 
vimentin  expression during myogenesis (46).  The resulting 
IF  gene  construct  pVDes  (10.5 kbp  without  plasmid  se- 
quences) consists of the complete coding region of the des- 
min gene and additional 5' and 3' untranslated  regions, fused 
to 3.2 kbp of vimentin  upstream sequences (Fig.  1 A; see 
Materials and Methods). 
After removal of plasmid sequences the pVDes gene was 
injected  into  the most accessible pronucleus  of fertilized 
mouse eggs. Southern blot analysis of tail DNA of mice born 
from these manipulated  eggs showed that 5 of 32 mice had 
incorporated  multiple  copies of the construct into their ge- 
nome in a head-to-tail  tandem array. Three of these (strains 
426, 429, and 430) produced offspring, all of which inherited 
the pVDes transgene  (Fig.  1 B). Southern blot analysis re- 
vealed no detectable rearrangements  in the pVDes sequences 
(data not shown). Offspring from founders 426 and 429 con- 
tained ,x,25 and 30 copies, respectively,  whereas 430 and its 
offspring had incorporated only 3 pVDes copies.  F~ and F2 
analysis showed that integration  had taken place into single 
loci. 
gissue-specific pVDes Expression 
The desmin expression pattern in tissue sections from trans- 
genic mouse strains 426, 429, and 430 and from control mice 
was analyzed by the indirect immunofluorescence  technique, 
using polyclonal rabbit antisera directed against desmin (poly- 
des), vimentin  (poly-vim),  and cytokemtins (poly-ker)  (51, 
52).  From transgenic  mice 427 and 428 only tail  sections 
were examined.  From mouse strains  426,  429,  and 430 a 
number of tissues was analyzed and for each of these strains 
at least two male and female mice were used. 
Cells expressing vimentin but not desmin in tissues from 
control mice (e.g.,  fibroblasts,  endothelial  cells,  cartilage, 
Kupffer cells, macrophages,  Schwann cells) displayed inten- 
sive staining in transgenic tissues after incubation  with poly- 
des and with poly-vim (Fig. 2). Occasionally,  a filamentous 
staining  pattern  was observed, suggesting  that  the pVDes- 
encoded desmin had assembled into IFs (Fig.  2, g and h). 
Epithelial  tissues stained  with poly-ker but not with poly- 
des.  In transgenic  striated  muscle tissue, connective tissue 
fibroblasts  not only expressed vimentin (Fig.2 i) but also 
desmin,  both in skeletal  (Fig.  2 k) and heart muscle (not 
shown).  All five transgenic  mice and their offspring (from 
426, 429, and 430) expressed pVDes in a vimentin-specific 
fashion.  Surprisingly,  in  testis  from  the  three  transgenic 
mouse strains Sertoli and Leydig cells, although expressing 
vimentin,  deviated from all other tissues tested (listed in leg- 
end to Fig. 2) in that they did not contain detectable amounts 
of desmin (Fig.  2, l-o). 
We did not observe any morphological effects of pVDes ex- 
Pieper et al.  Transgenic Expression of Desmin  1011 Figure 2. Expression of desmin and vimentin in tissues from control and transgenic mice as detected with the indirect immunofluorescence 
assay using poly-des and poly-vim. (a-c) Tail skin from control (a and b) and transgenic  (c) mice incubated with poly-vim (a) and poly-des 
(b and c). E, epidermis; H, hair follicle.  (d-f) Esophagus from control (d and e) and transgenic  (f) mice incubated  with poly-vim (d) 
and poly-des (e and f). Arrow indicates  desmin-positive  Langerhans cells.  M, muscle tissue;  E, epithelial  tissue.  (g and h) Cells from blood smears of  transgenic mice showing a filamentous staining pattern after incubation with poly-des. (i-k) striated muscle tissue of  control 
(i and j) and transgenic  (k) mice incubated  with poly-vim (t) and poly-des (j and k).  Note stainlng  of transgenic  muscle and nonmuscle 
cells with poly-des.  (l-o) Testis tissue from control (l and m) and transgenic  (n and o) mice incubated with poly-vim (l and n) and poly-des 
(m and o). Note presence of desmin only in myoid cells and blood vessel smooth muscle cells in both control and transgenic  testis tissues. 
Other tissues  investigated  include  kidney,  liver,  spleen,  heart, brain, tongue,  bladder,  uterus,  and prostate.  Bars,  4 ~m. Figure 3.  Characterization of pVDes protein from eye lens. (A) Coomassie Brilliant Blue (CBB)-stafined SDS-polyacrylamide  gels with 
equal amounts of total lens extracts from control (C) and transgenic mice (strains 426, 429, and 430). (B) Immunoblots of  total lens extracts 
from control (C) and transgenic mice (strains 426, 429, and 430) incubated with the monoclonal antibody to desmin (RD301; redes) and 
then with the monoclonal antibody to vimentin (RV202; mVim). Cytoskeletal proteins from BHK-21 cells were used as markers. (C) Total 
lens extracts of control (I and 4) and transgenic mice from strains 429 (2 and 5) and 430 (3 and 6) analyzed by two-dimensional PAGE 
and immunoblotting. Blots were incubated with RD301  (reDes) and then with RV202  (raVim). 
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velopmental or physiological abnormalities. 
Characterization of  In Vivo-synthesized 
pVDes Protein 
To identify biochemically and characterize the in vivo-syn- 
thesized pVDes protein,  we analyzed eye lens extracts from 
transgenic mouse strains 426, 429, and 430. Eye lens tissue 
has the advantage of expressing high levels of vimentin in the 
absence of desmin (50). One-dimensional SDS-PAGE analy- 
sis of total lens extracts (Fig. 3 A) and cytoskeletal fractions 
(not shown), followed by immunoblotting with monoclonal 
antibodies to desmin (RD301; 4) and vimentin (RV202; 4), 
showed that  the pVDes protein  is expressed  in transgenic 
lenses  (Fig.  3,  A  and B).  Immunoblotting  of two-dimen- 
sional gels from total lens extracts (Fig. 3 C) confirmed the 
identity of the pVDes protein, which comigrated with desmin 
from BHK-21 hamster cells (not shown).  Eye lenses from 
strains 426 and 429 contain comparable amounts of desmin. 
A  relatively low concentration  of hamster desmin was de- 
tected in strain 430 lenses (Fig. 3). As judged from Coomas- 
sie Brilliant Blue-stained gels and immunoblots of both total 
lens extracts and cytoskeletal fractions, lens vimentin expres- 
sion levels were not influenced by pVDes expression. 
In Vivo Expression Levels of  pVDes 
To determine the pVDes mRNA expression levels in different 
tissues and its influence on endogenous vimentin and desmin 
expression,  RNA from transgenic  and control tissues was 
analyzed by Northern blotting. We also included RNA from 
transgenic mice which express the vimentin-desmin  hybrid 
gene pVVim2 (36). In this construct, the last three exons of 
the vimentin gene have been replaced by the last three exons 
of the desmin gene,  allowing the detection of the pVVim2 
transcript  with  a  desmin-specific  probe.  Blots  were  first 
hybridized  to  a  vimentin-specific  probe  (E49;  Fig.  1 A), 
which  recognizes  both  endogenous  vimentin,  pVDes  and 
pVVim2 transcripts,  and subsequently to a desmin-specific 
probe (X54; Fig. 1 A). In control tissues only a 2.0-kb mRNA 
band was detected,  representing  the mouse vimentin mes- 
senger (e.g., Fig. 4 A, lane 4). In transgenic tissues an addi- 
tional 2.4- or 2.3-kb band was observed that corresponds to 
the correctly sized pVDes transcript  (e.g.,  Fig. 4 A, lanes 
1-3) or the pVVim2 transcript,  respectively (e.g., Fig. 4 A, 
lanes 5 and 6). Primer extension analysis showed that tran- 
scription  started  at  the  authentic  initiation  site  (data  not 
shown). Expression levels were determined by densitometric 
scanning  of autoradiographs  from  blots  containing  equal 
amounts of RNA. Actin mRNA levels served as a standard. 
The levels of vimentin mRNA did not differ between control 
and transgenic tissues (Fig. 4). Relative to mouse vimentin 
mRNA,  the  amount  of pVDes  transcripts  varied  between 
different tissues. In skeletal muscle tissue, pVDes expression 
was  relatively  high,  exceeding  mouse  vimentin  transcript 
levels (Fig.  4 A).  Both pVDes and pVVim2 mRNA levels 
were identical for skeletal muscle tissue from different parts 
of the body (Fig. 4 A, lanes 1, 2, 5, and 6). The lowest pVDes 
expression levels were detected in heart tissue (Fig.  4 B). 
Again,  no pVDes expression  was observed in  testis  from 
different transgenic strains (Fig. 4 C) indicating that the lack 
of expression in Sertoli and Leydig cells is caused at the level 
of transcription  or as a result of mRNA instability. In con- 
trast, pVVim2 was expressed at high levels in testis of trans- 
genic mice (Fig. 4 C, lane 4). Generally, pVDes expression 
levels were higher in tissues from strain 429 than in corre- 
sponding tissues from strain 426 (data not shown). An excep- 
tion is skeletal muscle tissue, which in strain 426 contained 
almost twice the amount of pVDes mRNA found in strain 
429 (Fig.  4  C).  The relative levels of pVVim2 expression 
also varied  between different tissues  and  were highest  in 
skeletal muscle. 
In Vitro Expression of  pVDes 
Transgenic cell lines were established by immortalization of 
ear-shell fibroblasts from offspring of strains 426, 429, and 
430  with  SV40.  Double-label  immunofluorescence  assays 
showed that  in  each  of these cell  lines  both  desmin  and 
vimentin are expressed and assembled into filamentous struc- 
tures (Fig. 5 A). In assays where the polyclonal vimentin an- 
tiserum and the monoclonal antibody to desmin were com- 
bined, vimentin and desmin staining intensities were about 
equal for cell lines 426 and 429, whereas cells from line 430 
showed a much weaker desmin staining intensity. Upon incu- 
bation of line 430 fibroblasts with poly-des, this difference 
was not observed. Generally, there was a complete match of 
desmin and vimentin filaments (Fig. 5 A, c and d). Double- 
immunogold  labeling of control and transgenic  fibroblasts 
revealed that the pVDes protein coassembled into bona fide 
IFs together with endogenous vimentin (Fig. 5 B, a-e). 
The pVDes and vimentin expression levels of the trans- 
genic  cell  lines  were analyzed  by Northern  blot  analysis 
using desmin- and vimentin-specific probes (Fig.  6, A and 
B). The pVDes transcript was of the expected size (2.4 kb) 
and was detected in all three cell lines (Fig. 6 A).  For cell 
line 430, the pVDes mRNA level was 20-fold lower than that 
of mouse vimentin mRNA.  In contrast,  cell lines 426 and 
429 showed pVDes mRNA levels that were similar to those 
of the endogenous vimentin. The amount of vimentin mRNA 
(2.0 kb) was not influenced by pVDes expression (Fig. 6 B). 
This was also observed for a pVVirn2  expressing ear-shell 
fibroblast cell line (strain 32; 36), which was cultured in par- 
allel (Fig. 6 B). As in transgenic tissues, pVDes mRNA was 
less abundant than pVVirn2  mRNA. 
To identify the pVDes protein in the fibroblast cell lines 
and determine the correlation between transcript and protein 
levels in vitro, the relative amounts of IF protein in cytoskele- 
tal fractions of the transgenic cell lines were analyzed by one- 
dimensional SDS-PAGE (Fig. 7). Desmin and vimentin were 
identified by immunoblotting with monoclonal antibodies to 
desmin (RD301) and vimentin (RV202), subsequently (Fig. 
7 B). The pVDes protein has an apparent molecular mass of 
54 kD and cannot be distinguished from hamster desmin of 
BHK-21  cells.  Coomassie  Brilliant  Blue-stained  gels  re- 
flected the levels of IF mRNA (Fig.  6) at the protein level 
(Fig.  7 A). 
Induction of  pVDes Expression in Tissue Culture 
In liver tissue, hepatocytes express specific cytokeratins and 
completely lack vimentin (16).  Culturing of rat hepatocytes 
induces vimentin expression (17).  Indirect immunofluores- 
cence assays with poly-vim, poly-des, and poly-ker on frozen 
sections of liver from control and transgenic mice confirmed 
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total  RNA  from  skeletal muscle  (A), heart 
(B), and testis (C) from control and transgenic 
mice.  Blots were  hybridized to  a  vimentin- 
(E49; Vim)  and then to a desmin-specific probe 
(X54; Des). The minor additional band above 
the desmin mRNA position was observed in all 
tissues and probably represents a splicing inter- 
mediate or is derived from a cryptic initiation 
site. After dehybridization the blots were hy- 
bridized to an actin probe (Act) that recognizes 
both ct-actin (1.8 kbp) and ~/3,-actin  transcripts 
(2.1 kbp). A similar analysis was performed on 
RNA  from kidney, liver, spleen,  brain,  and 
lens (results not shown). (A) RNA from skele- 
tal muscle of  abdomen (lanes 1, 3, 4, and 5) and 
thigh  (lanes 2  and  6).  (Lanes  1,  2,  and 8) 
pVDes strain 426; (lanes 3) 429; (lanes 4) con- 
trol; (lanes 5-7) pVVim2 strain 44. To illustrate 
the difference in length between pVVim2 and 
pVDes transcripts  (2.3  and 2.4 kbp, respec- 
tively) RNA from strains 44 and 426 was run 
on a longer gel and hybridized to E49 (lanes 7 
and 8). (B) RNA from heart tissue. (Lanes 1) 
pVDes strain 426; (lanes 2) 429; (lanes 3) con- 
trol;  (lanes 4) pVVim2 strain 44. To identify positively pVdes and endogenous desmin mRNA, longer exposure times, low stringency 
washes, and longer gels were used (lanes 2' and 3'). (Lane 2') As for lane 2, hybridized to E49; (lane 2") as for lane 2', hybridized to E49 
and X54, subsequently; (lane 3') as for lane 3 hybridized to E49 and X54, subsequently. (lanes 1-4) Exposure time and gel length as 
in Fig. 4, a and c. (C) RNA from testis. (Lanes 1) pVDes strain 426; (lanes 2) 429; (lanes 3) control; and (lanes 4) pVVim2 strain 44. 
After hybridization to X54 and long exposure times, a faint 2.3-kbp band was observed in lanes 1-3, representing endogenous desmin 
(not shown). 
that hepatocytes express only cytokeratins, whereas Kupffer 
cells express vimentin in control mice and also desmin in 
transgenic mice. 
Hepatocytes from control and transgenic mice (strains 426 
and 429) were isolated, cultured as a  monolayer, and ana- 
lyzed for IF expression by the indirect immunofluorescence 
assay during 4 d of culture. In all cases, the onset of vimentin 
synthesis was observed after 12-14 h (Fig. 8). At this point, 
vimentin expression occurred in only few cells and staining 
intensities were low. In addition, the filaments were not dis- 
tributed uniformly throughout the cell but were located at the 
periphery (Fig. 8). Within the next 30--40 h, the number of 
vimentin-containing cells  and  the  amount  of vimentin  in 
each cell increased until amost every cell was vimentin posi- 
tive. Cytokeratins were expressed continuously and did not 
colocalize with vimentin filaments (Fig. 8, f  and g). About 
25 h  after the earliest detection of vimentin in the immu- 
nofluorescence assays, hepatocytes from transgenic mice of 
strain 429 initiated expression of desmin (Fig. 9, a  and b). 
Again, a gradual increase in expression over a 40-h period 
was observed until most cells were desmin positive. In con- 
trol  hepatocytes,  desmin  expression was  never observed. 
Eventually, desmin and vimentin staining patterns were iden- 
tical, suggesting copolymerization of these proteins. In cul- 
tured  hepatocytes from  four different transgenic  mice  of 
strain 426, desmin expression could not be detected (Fig. 9, 
e and f). Each of these mice, however, showed the tissue- 
specific expression pattern that is characteristic of all pVDes 
transgenic mice and, as described, pVDes levels in strain 426 
were generally comparable to those of strain 429, both in tis- 
sues and in the fibroblast cell lines. To extend our analysis, 
hepatocytes of the two different pVVim2 transgenic mouse 
strains (Nos. 32 and 44; reference 36) were also brought into 
culture. Hepatocytes from these mice displayed vimentin and 
cytokeratin expression patterns,  which did not differ from 
those of  control and pVDes hepatocytes. Initiation of  pVVim2 
expression was observed 1 d later than vimentin expression. 
In summary, tissue culture-induced IF gene construct ex- 
pression occurred in three out of four transgenic strains. 
Discussion 
Expression of desmin in adult mammalian tissues occurs al- 
most exclusively in muscle cells. We have changed the tissue- 
specific distribution of this IF protein by creating transgenic 
mice, which express the IF gene construct pVDes, composed 
of the coding region of the hamster desmin gene and the 5' 
flanking region of the vimentin gene, in a vimentin-specific 
fashion. The pVDes protein was indistinguishable from ham- 
ster desmin. The levels of pVDes protein recovered in cyto- 
skeletal fractions from transgenic cell lines correlated with 
the pVDes mRNA levels, supporting the notion that IF syn- 
thesis is determined primarily by the amount of mRNA pres- 
ent (43, 46, 54, 58). Double-label immunofluorescence as- 
says and double-immunogold labeling of cultured transgenic 
ear fibroblast cells showed that the pVDes protein assembled 
into IFs that colocalized with the endogenous vimentin fila- 
ments. This is in agreement with previous reports concern- 
ing coexpression of desmin and vimentin in different types 
of  muscle cells (49, 62). Taken together, the data indicate that 
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the endogenous vimentin filaments. 
The in vivo expression pattern of the pVDes protein was 
determined by immunohistoehemical analysis of tissue sec- 
tions from different transgenic strains. Each transgenic mouse 
and all offspring expressed hamster desmin in a vimentin- 
specific fashion, pVDes expression did not delectably affect 
cellular morphology or differentiation. Desmin synthesis in 
vimentin-negative  cells was never observed. Surprisingly, no 
pVDes expression was detected in Sertoli and Leydig cells of 
all three lines of transgenic mice although these cells do ex- 
press vimentin (12, 66, 67; Fig. 2). This lack of expression 
is  either caused at the transcriptional level or by pVDes 
mRNA instability since no pVDes transcripts were detected 
in transgenic testis (Fig. 4  C). In contrast, an IF gene con- 
struct (pVVim2), consisting of the 5' flanking region and first 
six exons plus introns of the vimentin gene, fused to the last 
three exons and introns of the desmin gene is expressed in 
these testicular ceils. Since regulatory elements have been 
identified within introns of some genes (2, 26,  35, 45,  55, 
60), it is possible that such elements are located within the 
first six introns of the vimentin gene. 
An important aspect of gene regulation in general is the 
establishment of the appropriate  level  of expression.  For 
vimentin, questions concerning the mechanisms of this as- 
pect of regulation cannot be addressed by the use of cultured 
cells only, since it is unclear whether or not expression levels 
are  elevated upon  culturing of vimentin-expressing cells, 
overruling regulatory mechanisms active in vivo.  We show 
here that endogenous vimentin mRNA and protein levels 
were not influenced by pVDes  expression.  Obviously,  the 
amounts of IF protein are not strictly regulated and can be 
elevated without deleterious effects. 
The highest pVDes transcript levels were detected in skele- 
tal muscle tissue (Fig. 4). Immunohistochemical staining of 
striated muscle tissue sections showed that nonmuscle cells, 
which are included in this tissue, express both vimentin and 
pVDes  (Fig. 2).  Transgenic myoblasts presumably also ex- 
press these proteins. Since the pVDes encoded hamster des- 
min is indistinguishable from endogenous mouse desmin in 
these stainings, we cannot exclude the possibility that pVDes 
is also expressed in muscle cells of transgenic mice; e.g., as 
a  result of the presence  of muscle-specific regulatory se- 
quences within the introns of the desmin gene in addition to 
those present in the desmin gene 5' region (46).  However, 
pVVim2 mRNA levels were also highest in skeletal muscle 
tissue (Fig. 4), but it has been shown that the pVVim2 protein 
is not expressed in transgenic striated muscle cells (36). Fur- 
thermore,  in transgenic heart tissue pVDes  mRNA levels 
were low although endogenous desmin is expressed at high 
levels  (Fig. 4 B). 
Our  studies  on  cultured  hepatocytes establish  that  se- 
quences in the 3.2 kbp of 5' flanking region of the vimentin 
gene confer tissue culture-induced vimentin expression. In 
hepatocytes from pVDes strain 429,  desmin protein expres- 
sion was first observed after 40-50 h of culture, and lagged 
,,o25 h behind the initiation of vimentin synthesis. A similar 
time lag was observed in hepatocytes from pVVim2-express- 
ing mice. pVDes and pVVim2 transcripts also were detected 
,,old later than vimentin mRNA (data not shown). This lapse 
may result from differences in mRNA stabilities.  On the 
other hand, species differences in cis regulatory sequences 
of the hamster and mouse vimentin genes could explain the 
observed delay in desmin synthesis. Reports on vimentin ex- 
pression during avian and mammalian hematopoiesis have 
shown that divergence of cis-linked sequences can result in 
Pieper e! al, Transgenic Expression of Desmin  1017 Figure 5.  (A) Double-label  immunofluorescence  staining  of control (a and b) and transgenic  (c and d) transformed ear-shell  fibroblasts 
incubated  with poly-vim (a and c) and the monoclonal antibody to desmin RD301 (b and d). Note colocalization  of filaments stained by 
both antibodies  in transgenic  fibroblasts.  Bars, 4/~m. (B) Colocalization of desmin and vimentin in IFs of transgenic  cultured fibroblasts 
as seen at the ultrastructural  level after double-immunogold labeling. All preparations  were incubated with a mixture of secondary antibody- 
coated colloidal  gold probes in the detection  step. (a) IFs from transgenic  fibroblasts  incubated  with PBS instead of primary antibodies. 
(b and c) IFs from control (b) and transgenic (c) fibroblasts,  incubated with poly-vim and RD301, detected with 5- and 10-rim gold particles, 
respectively.  (d and e) IFs from transgenic  fibroblasts,  incubated  with poly-des and RV202,  detected  with 5- and 10-nm gold particles, 
respectively.  Bar,  200 nm. Figure 6. Not'them blot analysis of 10 ~g of total RNA from exponentially growing control (C) and transgenic transformed ear fibroblast 
cell lines (pVDes strains 426, 429, and 430; pVVim2 strain 32). To exclude clonal variation and influences of  growth conditions on expression 
levels, RNA was isolated from two independent cell lines for each pVDes strain. Blots were hybridized to a desmin-(A, X54, Des) and 
subsequently to a vimentin-specific probe (B, FA9, V/m). After dehybridization the blots were hybridized to an actin-specific probe (Act). 
Fibroblasts from strain 430 contained relatively little pVDes transcripts, which were readily detected, however, after longer exposure times 
(lanes 430'). 
F~gure 7. Cytoskeletal  fractions of  control 0anes 
1)  and  transgenic  (lanes  2-4)  transformed 
fibroblast cell  lines,  analyzed by one-dimen- 
ional  SDS-PAGE  and  immunoblotfing.  (.4) 
Coomassie  Brilliant  Blue  (CBB)  staining  of 
SDS-polyacrylamide gel.  (B)  Immunoblots, 
incubated with the monoclonal antibody to des- 
rain  (RD301,  redes)  and  subsequently  with 
the monoclonal antibody to v/mentin (RV202, 
mVim).  (Lane 1) Control fibroblasts; (lane 2) 
strain 426; (lane 3) strain 429; (lane 4) strain 
430. 
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man  neurofilament  (NF-L)  gene  expression  in  transgenic 
mice also differed from endogenous NF-L expression (31). 
Cultured hepatocytes  from  pVDes  strain 426  expressed 
vimentin, but no pVDes expression could be detected by in- 
direct  immunofluorescence  (Fig.  9)  and Northern blotting 
(data not shown). However, mice from this strain displayed 
tissue-specific  pVDes expression at similar levels as strain 
429. The site of integration of the pVDes copies in strain 426 
might not allow transcriptional activation under in vitro con- 
ditions. At the same time, regulatory processes in control of 
tissue-specific  and tissue culture-induced vimentin expres- 
sion may not be identical. We did not detect major rearrange- 
ments in the vimentin promoter region of the pVDes copies 
of strain  426.  It remains to be established exactly which 5' 
sequences  mediate  induction of vimentin synthesis in cul- 
tured cells. 
The reasons for the existence of the highly specific expres- 
sion patterns of desmin and vimentin are unknown. Although 
the  functional  differences  between  these  proteins  are  ob- 
scure, some different properties have been noted. Compari- 
son of hamster vimentin and desmin in vivo phosphorylation 
patterns  have  shown  that  desmin  contains  an  additional, 
subunit-specific phosphorylation site in the COOH-terminal 
"tail" region (10, 20). This might allow a differential response 
to exogenous stimuli and may reflect subunit-specific func- 
tions.  In addition,  it has been described that the "tail" do- 
mains of desmin and vimentin both associate with lamin B 
at the nuclear envelope but with different affinities (25). In 
double immunofluorescence assays on transgenic ear-shell 
fibroblast cells and cultured hepatocytes we observed a small 
percentage of cells that displayed large differences in desmin 
and vimentin staining intensities, suggesting that some fila- 
ments contained predominantly desmin or vimentin subunits. 
The same observation has been made for pVVim2-expressing 
cultured fibroblasts (36). This might reflect differences in as- 
sembly characteristics. 
The coexpression of desmin and vimentin in tissues and 
cultured cells from transgenic mice did not result in detect- 
able abnormalities. Future experiments, aimed at interfering 
with IF expression in vivo will hopefully shed some light on 
the function of these cytoskeletal  structures. 
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